Degludec insulin?

Insulin degludec (brand Tresiba) is a long-acting basal insulin analog used to control blood sugar in adults and children with type 1 or type 2 diabetes.

Key points:
- Duration and action: Ultra-long-acting basal insulin that provides a steady background level of insulin for about 24–42 hours.
- Dosing: Usually given once daily by subcutaneous injection. There are two formulations — U-100 (100 units/mL) and U-200 (200 units/mL) — for people who need higher doses.
- Timing: Dosing time can be flexible within a daily schedule (your clinician can advise the best window for you). Do not mix degludec in the same syringe with other insulins.
- Use with other insulins: It’s a basal insulin. If you use rapid-acting insulin for meals, you administer that separately.
- Starting and adjusting dose: The dose is individualized. A clinician typically starts with a low dose and titrates based on fasting blood glucose readings and targets.
- Common side effects: Hypoglycemia (low blood sugar) is the main risk, along with weight gain, injection-site reactions, and rare allergic reactions.
- Who can use it: Approved for adults and pediatric patients (generally 1 year and older) with diabetes.
- Storage: Unopened vials/injections in the fridge. After first use, follow the label for storage at room temperature and the discard timeframe.

If you have a specific question—like how it compares with other basal insulins (glargine, detemir), what starting dose might be right for you, or how it fits with a meal-time insulin—tell me more and I’ll tailor the info. And if you’re already using it and feel symptoms like dizziness, confusion, or sweating, seek medical advice promptly.